HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toru Sugiyama Selected Research

Mucinous Adenocarcinoma (Mucinous Carcinoma)

6/2018Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers.
3/2014Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancer.
2/2014Triple simultaneous primary invasive gynecological malignancies: a case report.
10/2012[Ovarian cancer-criteria of response and the timing of regimen change in chemotherapy for ovarian cancer].
9/2008Emerging drugs for ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toru Sugiyama Research Topics

Disease

76Neoplasms (Cancer)
01/2022 - 08/2002
38Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2002
27Carcinoma (Carcinomatosis)
01/2021 - 02/2002
26Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2022 - 01/2004
14Ovarian Epithelial Carcinoma
11/2021 - 07/2002
11Endometrial Neoplasms (Endometrial Cancer)
06/2019 - 08/2002
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2022 - 06/2008
8Disease Progression
01/2022 - 10/2012
6Adenocarcinoma
11/2019 - 08/2002
5Mucinous Adenocarcinoma (Mucinous Carcinoma)
06/2018 - 09/2008
5Neutropenia
01/2016 - 03/2011
5Anemia
01/2014 - 12/2011
4Fistula
09/2022 - 08/2018
4Neoplasm Metastasis (Metastasis)
01/2021 - 01/2018
4Endometrioid Carcinoma
06/2018 - 09/2006
4Lymphatic Metastasis
01/2018 - 06/2008
4Nausea
09/2017 - 03/2015
4Vomiting
09/2017 - 03/2015
4Thrombocytopenia (Thrombopenia)
01/2016 - 03/2011
4Carcinoid Tumor (Carcinoid)
10/2012 - 01/2010
4Vascular System Injuries
07/2011 - 07/2004
3Residual Neoplasm
11/2020 - 12/2006
3Diarrhea
01/2016 - 02/2002
3Leukopenia
01/2016 - 02/2002
3Febrile Neutropenia
01/2016 - 02/2003
3Ascites
07/2014 - 06/2008
3Cardiovascular Diseases (Cardiovascular Disease)
01/2014 - 09/2005
3Cushing Syndrome
01/2011 - 01/2010
3Ectopic ACTH Syndrome
01/2011 - 01/2010
3Pituitary ACTH Hypersecretion
01/2011 - 01/2010
3Clear Cell Adenocarcinoma
07/2010 - 02/2010
2Hypoxia (Hypoxemia)
11/2020 - 02/2010
2Hypertension (High Blood Pressure)
08/2018 - 04/2007
2Anorexia
09/2017 - 01/2016
2Carcinogenesis
05/2016 - 03/2010
2Carcinosarcoma
06/2015 - 12/2014
2Sarcoma (Soft Tissue Sarcoma)
12/2014 - 01/2004
2Adenoma (Adenomas)
01/2012 - 10/2010
2Pituitary Neoplasms (Pituitary Adenoma)
01/2011 - 01/2009
2Insulinoma
01/2010 - 08/2005
2Inflammation (Inflammations)
04/2007 - 10/2005
2Obesity
10/2006 - 01/2005
2Breast Neoplasms (Breast Cancer)
09/2006 - 10/2004
1Herpes Simplex
03/2021
1Adrenocortical Carcinoma
01/2021

Drug/Important Bio-Agent (IBA)

30Carboplatin (JM8)FDA LinkGeneric
01/2022 - 08/2005
30Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 02/2002
29PlatinumIBA
01/2022 - 05/2003
23Irinotecan (Camptosar)FDA LinkGeneric
11/2020 - 01/2002
18Cisplatin (Platino)FDA LinkGeneric
11/2020 - 01/2002
14taxaneIBA
10/2019 - 08/2007
12Proteins (Proteins, Gene)FDA Link
06/2018 - 09/2006
10Bevacizumab (Avastin)FDA Link
09/2022 - 02/2009
7Pharmaceutical PreparationsIBA
01/2018 - 02/2002
6liposomal doxorubicin (Doxil)FDA Link
11/2021 - 11/2008
6Docetaxel (Taxotere)FDA Link
06/2019 - 11/2010
51-dodecylpyridoxal (PLD)IBA
11/2021 - 11/2008
5AldosteroneIBA
01/2021 - 09/2005
5Hormones (Hormone)IBA
01/2011 - 10/2004
4GemcitabineFDA Link
11/2021 - 01/2013
42- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2020 - 12/2006
4nedaplatinIBA
08/2016 - 06/2008
4Octreotide (Sandostatin)FDA LinkGeneric
01/2012 - 01/2009
4Messenger RNA (mRNA)IBA
01/2012 - 09/2006
4Adrenocorticotropic Hormone (ACTH)FDA Link
01/2011 - 01/2010
3Doxorubicin (Adriamycin)FDA LinkGeneric
06/2019 - 06/2006
3Biomarkers (Surrogate Marker)IBA
08/2017 - 02/2010
3Somatostatin Receptors (Somatostatin Receptor)IBA
01/2011 - 01/2010
3Glucose (Dextrose)FDA LinkGeneric
01/2009 - 08/2005
2AntigensIBA
01/2022 - 07/2016
2Peptides (Polypeptides)IBA
11/2020 - 01/2004
2AntiemeticsIBA
09/2017 - 03/2015
2squamous cell carcinoma-related antigenIBA
07/2016 - 04/2015
2Biological ProductsIBA
07/2013 - 08/2002
2Antineoplastic Agents (Antineoplastics)IBA
01/2013 - 06/2012
2TubulinIBA
03/2012 - 06/2008
2Hemoglobins (Hemoglobin)IBA
12/2011 - 03/2011
2Transcription Factors (Transcription Factor)IBA
01/2011 - 10/2010
2EnzymesIBA
01/2011 - 01/2011
2Insulin-Like PeptidesIBA
01/2011 - 01/2009
2Etoposide (VP 16)FDA LinkGeneric
01/2011 - 08/2007
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2010 - 08/2005
2Insulin (Novolin)FDA Link
10/2006 - 08/2005
1NivolumabIBA
11/2021

Therapy/Procedure

54Drug Therapy (Chemotherapy)
01/2022 - 01/2002
35Therapeutics
01/2022 - 10/2004
18Hysterectomy
11/2019 - 12/2010
12Neoadjuvant Therapy
01/2019 - 07/2002
9Radiotherapy
09/2022 - 02/2003
5Adjuvant Chemotherapy
06/2019 - 08/2002
5Combination Drug Therapy (Combination Chemotherapy)
08/2018 - 05/2003
3Cytoreduction Surgical Procedures
01/2020 - 07/2002
3Lymph Node Excision (Lymph Node Dissection)
01/2019 - 11/2007
3Laparotomy
11/2017 - 07/2002
3Trachelectomy
10/2016 - 08/2015
3Chemoradiotherapy
08/2016 - 06/2008
2Ovariectomy (Oophorectomy)
01/2018 - 07/2002
2Salvage Therapy
05/2016 - 02/2003
2Cesarean Section (Caesarean Section)
01/2012 - 05/2010
1Re-Irradiation
09/2022